Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
JNMA J Nepal Med Assoc ; 57(220): 460-463, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-32335663

RESUMO

Thyrotoxic periodic paralysis is rare complication of hyperthyroidism characterized by the sudden onset of hypokalemia and muscle paralysis. It is typically present in young Asian males. There are very few literatures regarding the occurrence of thyrotoxic hypokalemic periodic paralysis in Nepal. We reported a case of a 35-year-old male presented with the chief complaints of weakness of all four limbs of 1 day duration. He was diagnosed as a case of hyperthyroidism in the past, received treatment for 6 months and left medications on his own 6 months ago. Evaluation during admission revealed severe hypokalemia with serum potassium level 1.3mEq/l and high serum Triiodothyronine (>20.00µg/L) and low serum Thyroid Stimulating Hormone (<0.01µg/L). Potassium supplements resolved muscle weakness and the patient was restarted with anti-thyroid drugs. Hence, hypokalemic paralysis is a reversible cause of paralysis and high index of suspicion as well as timely interventions are required to prevent potential harm. Keywords: hyperthyroidism; hypokalemia; muscle paralysis; thyrotoxic periodic paralysis.


Assuntos
Hipertireoidismo/fisiopatologia , Hipopotassemia/fisiopatologia , Paralisia/fisiopatologia , Adulto , Antiarrítmicos/uso terapêutico , Antitireóideos/uso terapêutico , Carbimazol/uso terapêutico , Humanos , Hipertireoidismo/complicações , Hipertireoidismo/tratamento farmacológico , Hipertireoidismo/metabolismo , Hipocalcemia/tratamento farmacológico , Hipocalcemia/etiologia , Hipocalcemia/metabolismo , Hipopotassemia/tratamento farmacológico , Hipopotassemia/etiologia , Hipopotassemia/metabolismo , Masculino , Adesão à Medicação , Paralisia/tratamento farmacológico , Paralisia/etiologia , Periodicidade , Potássio/uso terapêutico , Propranolol/uso terapêutico , Tireotropina/metabolismo , Tri-Iodotironina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA